Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | STAT3 | P40763 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | CA3 | P07451 | 1/20 | 0.38 |
| ▸ | CA6 | P23280 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.38 |
| ▸ | VDR | P11473 | 1/20 | 0.38 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17302747 | 0.91 | ALDH1A1 (0.43) | CA9CA2CA12CA1GAA | |
| SCHEMBL23611478 | 0.91 | ALDH1A1 (0.43) | CA9CA2CA12CA1GAA | |
| SCHEMBL278880 | 0.90 | ALDH1A1 (0.41) | CA9CA2CA12CA1GAA | |
| SCHEMBL2845979 | 0.89 | CA12 (0.40) | CA9CA2CA12CA1GAA | |
| SCHEMBL23015111 | 0.87 | CA12 (0.39) | CA9CA2CA12CA1GAA | |
| SCHEMBL21149355 | 0.87 | CA12 (0.39) | CA9CA2CA12CA1GAA | |
| SCHEMBL1016996 | 0.87 | CA12 (0.39) | CA9CA2CA12CA1GAA | |
| SCHEMBL23832592 | 0.87 | CA12 (0.39) | CA9CA2CA12CA1GAA | |
| SCHEMBL25371249 | 0.87 | CA12 (0.39) | CA9CA2CA12CA1GAA | |
| SCHEMBL25362116 | 0.87 | CA12 (0.39) | CA9CA2CA12CA1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 460 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120059471-A | Modified emulsified asphalt and preparation method thereof | 中国石油化工股份有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-120059779-A | Modified asphalt for water-based drilling fluid and preparation method thereof | 中国石油化工股份有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-120059691-A | Water-in-oil-based drilling fluid and preparation method thereof | 中国石油化工股份有限公司 | 2025-05-30 | — | — | CN | claimed |
| US-11901508-B2 | Silicon-based energy storage devices with functionalized linear sulfonate ester derivative compound containing electrolyte additives | ENEVATE CORPORATION (US) | 2024-02-13 | — | — | US | claimed |
| CN-117199523-A | Electrolyte, secondary battery and electric equipment | 欣旺达动力科技股份有限公司 | 2023-12-08 | — | — | CN | claimed |
| US-20230006252-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONALIZED LINEAR SULFONATE ESTER DERIVATIVE COMPOUND CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2023-01-05 | — | — | US | claimed |
| US-11539077-B2 | Electrolyte additives containing one, two, or more triple-bonded moieties for silicon anode-based li-ion batteries | ENEVATE CORPORATION (US) | 2022-12-27 | — | — | US | claimed |
| CN-115458809-A | Electrolyte and lithium ion battery comprising same | 香河昆仑新能源材料股份有限公司 | 2022-12-09 | — | — | CN | claimed |
| WO-2022093792-A1 | ELECTROLYTE ADDITIVES CONTAINING ONE, TWO, OR MORE TRIPLE-BONDED MOIETIES FOR SILICON ANODE-BASED BATTERIES | ENEVATE CORPORATION (US) | 2022-05-05 | — | — | WO | claimed |
| US-20220131195-A1 | ELECTROLYTE ADDITIVES CONTAINING ONE, TWO, OR MORE TRIPLE-BONDED MOIETIES FOR SILICON ANODE-BASED LI-ION BATTERIES | ENEVATE CORPORATION | 2022-04-28 | — | — | US | claimed |
| CN-112778838-A | Inorganic nano material printing ink and preparation method thereof | 广东绿展科技有限公司 | 2021-05-11 | — | — | CN | claimed |
| US-20200388879-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONALIZED LINEAR SULFONATE ESTER DERIVATIVE COMPOUND CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-12-10 | — | — | US | claimed |
| WO-2005051381-A1 | Substituted urea-octatydroindols as antagonists of melanin concentrating hormone receptor 1 (MCH1R) | BIOVITRUM AB (SE) | 2005-06-09 | — | — | WO | claimed |
| US-12630531-B2 | Quinazoline-2,4-diamine derivative and pharmaceutical composition for preventing or treating cancer comprising same as active ingredient | OMIC SMAP INC. (KR) | 2026-05-19 | — | — | US | disclosed |
| US-20260062425-A1 | AZA-TETRACYCLIC OXAZEPINE COMPOUNDS AND USES THEREOF | GENENTECH INC (US) | 2026-03-05 | — | — | US | disclosed |
| WO-2025262297-A1 | PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 | DARK BLUE THERAPEUTICS LTD (GB) | 2025-12-26 | — | — | WO | disclosed |
| WO-1992007831-A1 | SUBSTITUTED TETRAHYDROPYRIDINES AND HYDROXYPIPERIDINES AS CENTRAL NERVOUS SYSTEM AGENTS | WARNER-LAMBERT COMPANY (US) | 1992-05-14 | — | — | WO | disclosed |
| WO-1992007832-A2 | SUBSTITUTED PIPERAZINES AS CENTRAL NERVOUS SYSTEM AGENTS | WARNER-LAMBERT COMPANY (US) | 1992-05-14 | — | — | WO | disclosed |
| US-4959361-A | Triazolo(4,3-A)(1,4)benzodiazepines and thieno (3,2-F)(1,2,4)triazolo(4,3-A)(1,4)diazepine compounds which have useful activity as platelet activating factor (PAF) antagonists | HOFFMANN-LA ROCHE INC. (US) | 1990-09-25 | — | — | US | disclosed |
| EP-0320992-A2 | Triazolodiazepine derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1989-06-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200388879-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONALIZED LINEAR SULFONATE ESTER DERIVATIVE COMPOUND CONTAINING ELECTROLYTE ADDITIVES | SELENOI, SELE, SORD | CA9 766/4885CA2 426/4885CA12 736/4885 |
| US-11901508-B2 | Silicon-based energy storage devices with functionalized linear sulfonate ester derivative compound containing electrolyte additives | SELENOI, SELE, SORD | CA9 766/4885CA2 426/4885CA12 736/4885 |
| US-20220131195-A1 | ELECTROLYTE ADDITIVES CONTAINING ONE, TWO, OR MORE TRIPLE-BONDED MOIETIES FOR SILICON ANODE-BASED LI-ION BATTERIES | SELENOI, SIK1, SIK2 | CA9 455/4885CA2 60/4885CA12 443/4885 |
| US-20260062425-A1 | AZA-TETRACYCLIC OXAZEPINE COMPOUNDS AND USES THEREOF | KRAS, NRAS, HRAS | CA9 338/4885CA2 340/4885CA12 346/4885 |
| US-12630531-B2 | Quinazoline-2,4-diamine derivative and pharmaceutical composition for preventing or treating cancer comprising same as active ingredient | EHMT2, EHMT1, HNMT | CA9 2784/4885CA2 1631/4885CA12 3549/4885 |
| US-11539077-B2 | Electrolyte additives containing one, two, or more triple-bonded moieties for silicon anode-based li-ion batteries | SELENOI, SIK1, SIK2 | CA9 455/4885CA2 60/4885CA12 443/4885 |
| US-20230006252-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONALIZED LINEAR SULFONATE ESTER DERIVATIVE COMPOUND CONTAINING ELECTROLYTE ADDITIVES | SELENOI, SELE, SORD | CA9 766/4885CA2 426/4885CA12 736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.